Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration

International Immunopharmacology

Volumn 15, Issue 3, 2013, Pages 646-653

  Shao, Congwen ^a   Tian, Guojun ^a   Huang, Yuanjian ^a   Liang, Wenying ^a   Zheng, Hang ^a   Wei, Jiannan ^a   Wei, Cheng ^b   Yang, Cuilan ^a   Wang, Hong ^a   Zeng, Weisen ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Bifidobacterium; Maturation; Oral administration; T cell; Thymosin alpha 1; Transformation

Indexed keywords

ARABINOSE; GAMMA INTERFERON; INTERLEUKIN 12; THYMOSIN ALPHA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIFIDOBACTERIUM LONGUM; BLOOD; CD4 CD8 RATIO; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; THYMUS; THYMUS HYPERPLASIA;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; BIFIDOBACTERIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONING, MOLECULAR; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; THYMOSIN; TRANSFORMATION, BACTERIAL; TRANSGENES;

EID: 84874930248     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.12.031     Document Type: Article

References (44)

1. A. Ahmed, D.M. Wong, G.B. Thurman, T.L. Low, A.L. Goldstein, and S.J. Sharkis T-lymphocyte maturation: cell surface markers and immune functions induced by T-lymphocyte cell-free products and thymosin polypeptides Ann N Y Acad Sci 332 1979 81 94
2. P. Andreone, A. Gramenzi, C. Cursaro, F. Felline, E. Loggi, and A. D'Errico Thymosin alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial J Viral Hepat 11 1 2004 69 73
3. A. Argnani, R.J. Leer, N. van Luijk, and P.H. Pouwels A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium Microbiology 142 Pt 1 1996 109 114
4. S. Bozza, R. Gaziano, P. Bonifazi, T. Zelante, L. Pitzurra, and C. Montagnoli Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo Int Immunol 19 11 2007 1261 1270
5. J.V. Castell, G. Friedrich, C.S. Kuhn, and G.E. Poppe Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake Am J Physiol 273 1 1997 139 146
6. D. Chadwick, J. Pido-Lopez, A. Pires, N. Imami, F. Gotch, and J.S. Villacian A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy Clin Exp Immunol 134 3 2003 477 481
7. H.L. Chan, J.L. Tang, W. Tam, and J.J. Sung The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis Aliment Pharmacol Ther 15 12 2001 1899 1905
8. L.M. Dicks, and M. Botes Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action Benefic Microbes 1 1 2010 11 29
9. C. Favalli, T. Jezzi, A. Mastino, C. Rinaldi-Garaci, C. Riccardi, and E. Garaci Modulation of natural killer activity by thymosin alpha 1 and interferon Cancer Immunol Immunother 20 3 1985 189 192
10. E. Garaci, C. Favalli, F. Pica, P. Sinibaldi Vallebona, A.T. Palamara, and C. Matteucci Thymosin alpha 1: from bench to bedside Ann N Y Acad Sci 1112 2007 225 234
11. C. Giuliani, G. Napolitano, A. Mastino, S. Di Vincenzo, C. D'Agostini, and S. Grelli Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level Eur J Immunol 30 3 2000 778 786
12. A.L. Goldstein, and M. Badamchian Thymosins: chemistry and biological properties in health and disease Expert Opin Biol Ther 4 4 2004 559 573
13. A.L. Goldstein, T.L. Low, M. McAdoo, J. McClure, G.B. Thurman, and J. Rossio Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide Proc Natl Acad Sci U S A 74 2 1977 725 729
14. J.W. Hadden, E. Verastegui, and E. Hadden IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans Ann N Y Acad Sci 1112 2007 245 255
15. Y. Huang, Z. Chen, C. Zhou, H. Yao, M. Li, and C. Xu The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha Int Immunopharmacol 4 4 2004 539 546
16. S. Kapoor The rapidly expanding therapeutic role of thymosin α-1 in the management of gastrointestinal and systemic infectious disorders J Intensive Care Med 24 3 2009 210 211
17. K.D. Leichtling, S.A. Serrate, and M.B. Sztein Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes Int J Immunopharmacol 12 1 1990 19 29
18. C.Y. Li, H.C. Lin, C.H. Lai, J.J. Lu, S.F. Wu, and S.H. Fang Immunomodulatory effects of lactobacillus and Bifidobacterium on both murine and human mitogen-activated T cells Int Arch Allergy Immunol 156 2 2011 128 136
19. J. Li, C.H. Liu, and F.S. Wang Thymosin alpha 1: biological activities, applications and genetic engineering production Peptides 31 11 2010 2151 2158
20. X. Li, G.F. Fu, Y.R. Fan, W.H. Liu, X.J. Liu, and J.J. Wang Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth Cancer Gene Ther 10 2 2003 105 111
21. Y.M. Li, H. Chen, X. Li, W.C. Zhou, M.Y. He, and M. Chiriva-Internati A new immunomodulatory therapy for severe sepsis: ulinastatin plus thymosin α 1 J Intensive Care Med 24 1 2009 47 53
22. R.T. Long, W.S. Zeng, L.Y. Chen, J. Guo, Y.Z. Lin, and Q.S. Huang Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice Int J Obes (Lond) 34 4 2010 712 719
23. T.W. Moody Thymosin α1 as a chemopreventive agent in lung and breast cancer Ann N Y Acad Sci 1112 1 2007 297 304
24. P.H. Naylor, K. Quadrini, E. Garaci, G. Rasi, and J.W. Hadden Immunopharmacology of thymosin α1 and cytokine synergy Ann N Y Acad Sci 1112 1 2007 235 244
25. X. Peng, P. Zhang, X. Wang, J. Chan, M. Zhu, and M. Jiang Signaling pathways leading to the activation of IKK and MAPK by thymosin α1 Ann N Y Acad Sci 1112 1 2007 339 350
26. Y. Peng, Z. Chen, W. Yu, Q. Zhou, L. Xu, and F.F. Mao Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells Cell Biol Int 32 10 2008 1265 1271
27. A. Mastino, C. Favalli, S. Grelli, G. Rasi, F. Pica, and A.L. Goldstein Combination therapy with thymosin a1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice Int J Cancer 50 1992 493 499
28. L. Romani, F. Bistoni, R. Gaziano, S. Bozza, C. Montagnoli, and K. Perruccio Thymosin α 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling Blood 103 11 2004 4232 4239
29. R. Roy, S.M. Singh, A. Shanker, and A. Sodhi Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1 Int J Immunopharmacol 22 4 2000 309 321
30. D.A. Russell, R.P. Ross, G.F. Fitzgerald, and C. Stanton Stanton metabolic activities and probiotic potential of bifidobacteria Int J Food Microbiol 149 1 2011 88 105
31. V.K. Rustgi Thymalfasin for the treatment of chronic hepatisis C infection Expert Rev Anti Infect Ther 3 6 2005 885 892
32. R.S. Schulof, M.J. Lloyd, P.A. Cleary, S.R. Palaszynski, D.A. Mai, and J.W. Cox Jr. A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer J Biol Response Mod 4 2 1985 147 158
33. K.E. Sherman Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof Ann N Y Acad Sci 1194 2010 136 140
34. M.H. Sjogren Thymalfasin: an immune system enhancer for the treatment of liver disease J Gastroenterol Hepatol 19 S6 2004 S69 S72
35. A. Sodhi, and S. Paul Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1 Int Immunopharmacol 2 1 2002 47 58
36. C. Tuthill, I. Rios, and R. McBeath Thymosin alpha 1: past clinical experience and future promise Ann N Y Acad Sci 1194 1 2010 130 135
37. Y. Umeda, A. Sakamoto, J. Nakamura, H. Ishitsuka, and Y. Yagi Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays Cancer Immunol Immunother 15 2 1983 78 83
38. X. Wang, W. Li, C. Niu, L. Pan, N. Li, and J. Li Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study Inflammation 34 3 2011 198 202
39. B.S. Worthington, E.S. Boatman, and G.E. Kenny Intestinal absorption of intact proteins in normal and protein-deficient rats Am J Clin Nutr 27 3 1974 276 286
40. J.F. Yang, L.Y. Qiu, Y. Jin, and J.X. Zhang Thymosin-loaded enteric microspheres for oral administration: preparation and in vitro release studies Int J Pharm 301 1 2005 41 47
41. X. Yang, F. Qian, H.Y. He, K.J. Liu, Y.Z. Lan, and B. Ni Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro Braz J Med Biol Res 45 1 2012 25 32
42. J. Yao, J.Y. Wang, M.G. Lai, Y.X. Li, H.M. Zhu, and R.Y. Shi Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum Mol Pharm 8 2 2011 488 497
43. W. Yao, Q. Zhu, Y. Yuan, M. Qiao, Y. Zhang, and Z. Zhai Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level J Gastroenterol Hepatol 22 11 2007 1866 1871
44. Z. Yu, Z. Huang, C. Shao, Y. Huang, F. Zhang, and J. Yang Oral administration of IFN-a2b-transformed B. longum protects the Balb/c mice against coxsackievirus B3-induced myocarditis Virol J 8 2011 525 530